Description
Ziconotide is a synthetic version of ω-conopeptide MVIIA, a peptide toxin originally found in the venom of the fish-eating marine snail
C. magus, that blocks N-type calcium channels in rat brain membranes (K
ds = 1.1-18 pM; IC
50s = 2-55 pM).
1,
2 It blocks high-voltage-activated calcium currents in rat superior cervical ganglion neurons (IC
50 = 32 nM) as well as depolarization-induced norepinephrine release by rat peripheral sympathetic efferent neurons and in rat hippocampus (IC
50s = 1.2 and 5.5 nM, respectively).
1 Intrathecal administration of ziconotide inhibits formalin-induced flinch responses and increases the paw withdrawal threshold in the paw pressure test in rats (ED
50s = 0.11 and 0.60 μg, respectively), indicating antinociceptive effects.
3 It decreases latency to tail withdrawal in a hot plate test in a rat model of sciatic chronic constriction injury.
1 Ziconotide also reduces infarct volume post ischemia in a rat model of transient focal ischemia.
4
References
1. McGivern, J.G.
Ziconotide: A review of its pharmacology and use in the treatment of pain Neurophyschiatr. Dis. Treat. 3(1),69-85(2007).
2. Olivera, B.M., Cruz, L.J., de Santos, V., et al.
Neuronal calcium channel antagonists. Discrimination between calcium channel subtypes using ω-conotoxin from Conus magus venom Biochemistry 26(8),2086-2090(1987).
3. Wang, Y.X., Gao, D., Pettus, M., et al.
Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats Pain 84(2-3),271-281(2000).
4. Zhao, Q., Smith, M.L., and Siesj, B.K.
The omega-conopeptide SNX-111, an N-type calcium channel blocker, dramatically ameliorates brain damage due to transient focal ischaemia Acta. Physiol. Scand. 150(4),459-461(1994).